Last reviewed · How we verify

BPX-01 2% Minocycline Topical Gel

BioPharmX, Inc. · Phase 2 active Small molecule

BPX-01 2% Minocycline Topical Gel is a tetracycline antibiotic Small molecule drug developed by BioPharmX, Inc.. It is currently in Phase 2 development for Acne. Also known as: BPX-01 Topical Gel.

Minocycline is a tetracycline antibiotic that inhibits protein synthesis by binding to the 30S ribosomal subunit.

Minocycline is a tetracycline antibiotic that inhibits protein synthesis by binding to the 30S ribosomal subunit. Used for Acne.

At a glance

Generic nameBPX-01 2% Minocycline Topical Gel
Also known asBPX-01 Topical Gel
SponsorBioPharmX, Inc.
Drug classtetracycline antibiotic
Target30S ribosomal subunit
ModalitySmall molecule
Therapeutic areaInfectious Disease
PhasePhase 2

Mechanism of action

Minocycline has broad-spectrum antimicrobial activity against a wide range of bacteria, including both Gram-positive and Gram-negative organisms.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about BPX-01 2% Minocycline Topical Gel

What is BPX-01 2% Minocycline Topical Gel?

BPX-01 2% Minocycline Topical Gel is a tetracycline antibiotic drug developed by BioPharmX, Inc., indicated for Acne.

How does BPX-01 2% Minocycline Topical Gel work?

Minocycline is a tetracycline antibiotic that inhibits protein synthesis by binding to the 30S ribosomal subunit.

What is BPX-01 2% Minocycline Topical Gel used for?

BPX-01 2% Minocycline Topical Gel is indicated for Acne.

Who makes BPX-01 2% Minocycline Topical Gel?

BPX-01 2% Minocycline Topical Gel is developed by BioPharmX, Inc. (see full BioPharmX, Inc. pipeline at /company/biopharmx-inc).

Is BPX-01 2% Minocycline Topical Gel also known as anything else?

BPX-01 2% Minocycline Topical Gel is also known as BPX-01 Topical Gel.

What drug class is BPX-01 2% Minocycline Topical Gel in?

BPX-01 2% Minocycline Topical Gel belongs to the tetracycline antibiotic class. See all tetracycline antibiotic drugs at /class/tetracycline-antibiotic.

What development phase is BPX-01 2% Minocycline Topical Gel in?

BPX-01 2% Minocycline Topical Gel is in Phase 2.

What are the side effects of BPX-01 2% Minocycline Topical Gel?

Common side effects of BPX-01 2% Minocycline Topical Gel include Nausea, Diarrhea, Vomiting.

What does BPX-01 2% Minocycline Topical Gel target?

BPX-01 2% Minocycline Topical Gel targets 30S ribosomal subunit and is a tetracycline antibiotic.

Related